Team |
Clayton Morrison, PhD
Clayton Morrison, PhD

Clayton Morrison, PhD

Senior Scientist

Genome Editing

Clayton is focused on evaluating genome editing technology for therapeutic development at Life Edit Therapeutics. He has more than a decade of experience in cell and molecular biology. 

Prior to Life Edit, Clayton spent two years  developing  AAV-based gene therapy strategies as a Scientist at StrideBio.

Clayton received a BS in Microbiology from the University of Georgia, a MS in Biology from Georgia College and State University, and a PhD in Microbiology from North Carolina State University. He completed his postdoctoral training in genetics at the University of North Carolina, Chapel Hill.

Connect with

Visionary science, driven by visionary values.

Our Mission

To rewrite the future by curing disease, making any edit, anywhere.

Our Vision

To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.

Our Values

We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.